Table 4.
Enriched category | Gene set | Leading edge number | NES | FDR |
---|---|---|---|---|
Kinase target | Kinase_CDK1 | 84 | 2.5367 | 0 |
Kinase_PLK1 | 30 | 2.4679 | 0 | |
Kinase_AURKB | 34 | 2.2754 | 0 | |
Kinase_CDK2 | 90 | 2.1616 | 0 | |
Kinase_ATM | 38 | 2.0821 | 0 | |
miRNA target | GGGGCCC,MIR-296 | 27 | -1.5696 | 0.099967 |
CCTGTGA,MIR-513 | 47 | -1.579 | 0.11175 | |
AGCGCTT,MIR-518F,MIR-518E,MIR-518A | 7 | -1.5396 | 0.12257 | |
GAGCCTG,MIR-484 | 40 | -1.6427 | 0.13212 | |
CCCAGAG,MIR-326 | 49 | -1.5866 | 0.13432 | |
Transcription factor | V$E2F1_Q6 | 85 | 2.1908 | 0 |
V$E2F_Q6 | 81 | 2.1879 | 0 | |
V$E2F_Q4 | 81 | 2.1486 | 0 | |
V$E2F4DP1_01 | 82 | 2.147 | 0 | |
V$E2F1DP1_01 | 82 | 2.1346 | 0 |
LUAD: lung adenocarcinoma; NES: normalized enrichment score; FDR: false discovery rate.